Registration Options

Register for the meeting.

Session Time and Location

Date: Tuesday, 04/26/2022

Time: 8:45 AM (view in the schedule)

Room: TBD

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

The prescribing of clozapine is limited to treatment resistant schizophrenia due to concerns of agranulocytosis, resulting in frequent lab monitoring to reduce this risk. Patients with benign ethnic neutropenia (BEN) are prescribed clozapine less often without evidence to support this practice. This is a growing area of research that has the potential to improve clozapine prescribing for patients in whom it is currently being underutilized. As psychiatric and neurologic pharmacists, it is important to provide the best care to our patients presenting with BEN.

Faculty Information and Disclosures

Learning Objectives

  1. Recall the underutilization of clozapine, particularly in Black patients and the prevalence of neutropenia in this population.
  2. Discuss characterization and impact of Benign Ethnic Neutropenia (BEN) on Absolute Neutrophil Count and how to determine BEN in patients.
  3. Describe cutting-edge data on the outcomes of clozapine in Black patients and those with BEN and the relative risk of neutropenia and severe neutropenia in this population.

Continuing Education Credit and Disclosures

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.